摘要:
A circuit arrangement is disclosed comprising a transmitter/receiver unit (1), a control circuit (2) and a supply line (3). The transmitter/receiver unit (1) comprises a supply input (4) for connecting the supply line, an energy storage unit (5) that with a first connection is coupled to the supply input (4) and that is configured to guarantee an internal energy supply during a reduction of an average supply signal (VS) at the supply input (4) over a predetermined time period, a detection unit (6) that is coupled to the supply input (4) and that is configured to detect a reduction of the average supply signal (VS) over the predetermined time period and at which an evaluation signal (AS) can be tapped, and a data transmission unit (7) that is coupled to the detection unit (6) and to the supply input (4) and that is configured to send a data signal (SD) via the supply line, depending on the evaluation signal (AS).
摘要:
A control method for a system of a hand power tool and an accumulator battery is disclosed. The hand power tool is connectable to the accumulator battery via a current interface for supplying the hand power tool. The hand power tool features a data interface for communicating with the accumulator battery. Characterizing data of the hand power tool and/or data about an operating process of the hand power tool is transmitted to the accumulator battery via the interface.
摘要:
This invention relates to the use of folates for producing a pharmaceutical preparation suitable for the prevention and treatment of inflammation and of diseases associated with inflammation, particularly for influencing the inflammation markers C-reactive protein (CRP) and serum amyloid A protein (SAA). The clinical areas of application are all anomalies of the CRP and SAA levels.The invention also relates to pharmaceutical preparations for the prevention and treatment of inflammation and of diseases associated with inflammation, particularly for influencing CRP and SAA levels, characterised in that as an active ingredient it comprises at least one compound which is selected from the group consisting of pteroic acid monoglutamate (folic acid), dihydrofolic acid, 5-formyltetrahydrofolic acid, 5-methyltetrahydrofolic acid, 5,10-methylenetetrahydrofolic acid, 5,10-methenyl-tetrahydrofolic acid, 10-formyltetrahydrofolic acid or tetrahydrofolic acid, polyglutamates thereof, optical isomers thereof, particularly optically pure natural isomers thereof, and mixtures of optical isomers also, particularly racemic mixtures, as well as pharmaceutically acceptable salts thereof also, together with pharmaceutically acceptable active ingredients and adjuvants.